Biogen Idec to share latest neurology data at AAN 2014 Zenopa Further information will be shared on products such as Tysabri, Avonex, Fampyra, Anti-LINGO-1 and daclizumab high-yield process. Dr Alfred Sandrock, group senior vice-president and chief medical officer at Biogen Idec, said: "The breadth of data we are ... |
